164 related articles for article (PubMed ID: 37601051)
1. Jianpi Yangzheng Xiaozheng decoction alleviates gastric cancer progression via suppressing exosomal PD-L1.
Chen Y; Liu J; Chen Y; Zhang R; Tao J; Chen X; Wang H; Sun Q; Wu J; Liu S
Front Pharmacol; 2023; 14():1159829. PubMed ID: 37601051
[TBL] [Abstract][Full Text] [Related]
2. The effect of Jianpi Yangzheng Xiaozheng Decoction and its components on gastric cancer.
Wu J; Zhang XX; Zou X; Wang M; Wang HX; Wang YH; Li CY; Zhao LG; Chen M; Pei LX; Liu SL; Sun QM
J Ethnopharmacol; 2019 May; 235():56-64. PubMed ID: 30731181
[TBL] [Abstract][Full Text] [Related]
3. Metabolomic Study on the Therapeutic Effect of the Jianpi Yangzheng Xiaozheng Decoction on Gastric Cancer Treated with Chemotherapy Based on GC-TOFMS Analysis.
Hou C; Chu HJ; Dai XJ; Wu YQ; He ZF; Yu YW; Lu QY; Liu YQ; Zhang XC
Evid Based Complement Alternat Med; 2021; 2021():8832996. PubMed ID: 33790982
[TBL] [Abstract][Full Text] [Related]
4. Effect of modified Jianpi Yangzheng on regulating content of PKM2 in gastric cancer cells-derived exosomes.
Wu J; Yuan M; Shen J; Chen Y; Zhang R; Chen X; Wang H; Yin Z; Zhang X; Liu S; Sun Q
Phytomedicine; 2022 Aug; 103():154229. PubMed ID: 35691076
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiota-dependent modulation of pre-metastatic niches by Jianpi Yangzheng decoction in the prevention of lung metastasis of gastric cancer.
Zhu X; Zhang X; Shen J; Zheng S; Li H; Han B; Zhang C; Chen M; Sun Q; Wu J
Phytomedicine; 2024 Jun; 128():155413. PubMed ID: 38513377
[TBL] [Abstract][Full Text] [Related]
6. LSD1 deletion decreases exosomal PD-L1 and restores T-cell response in gastric cancer.
Shen DD; Pang JR; Bi YP; Zhao LF; Li YR; Zhao LJ; Gao Y; Wang B; Wang N; Wei L; Guo H; Liu HM; Zheng YC
Mol Cancer; 2022 Mar; 21(1):75. PubMed ID: 35296335
[TBL] [Abstract][Full Text] [Related]
7. Serum exosomal miR-16-5p functions as a tumor inhibitor and a new biomarker for PD-L1 inhibitor-dependent immunotherapy in lung adenocarcinoma by regulating PD-L1 expression.
Chen HL; Luo YP; Lin MW; Peng XX; Liu ML; Wang YC; Li SJ; Yang DH; Yang ZX
Cancer Med; 2022 Jul; 11(13):2627-2643. PubMed ID: 35347894
[TBL] [Abstract][Full Text] [Related]
8. Exosomal miRNA-16-5p Derived From M1 Macrophages Enhances T Cell-Dependent Immune Response by Regulating PD-L1 in Gastric Cancer.
Li Z; Suo B; Long G; Gao Y; Song J; Zhang M; Feng B; Shang C; Wang D
Front Cell Dev Biol; 2020; 8():572689. PubMed ID: 33330451
[TBL] [Abstract][Full Text] [Related]
9. A clinical study of traditional Chinese medicine prolonging the survival of advanced gastric cancer patients by regulating the immunosuppressive cell population: A study protocol for a multicenter, randomized controlled trail.
Pan X; Tao H; Nie M; Liu Y; Huang P; Liu S; Sun W; Wu J; Ma T; Dai A; Lu J; Liu B; Zou X; Sun Q
Medicine (Baltimore); 2020 Apr; 99(16):e19757. PubMed ID: 32311976
[TBL] [Abstract][Full Text] [Related]
10. Exosomal PD-L1 Retains Immunosuppressive Activity and is Associated with Gastric Cancer Prognosis.
Fan Y; Che X; Qu J; Hou K; Wen T; Li Z; Li C; Wang S; Xu L; Liu Y; Qu X
Ann Surg Oncol; 2019 Oct; 26(11):3745-3755. PubMed ID: 31087180
[TBL] [Abstract][Full Text] [Related]
11. Jianpi Huayu Decoction Attenuates the Immunosuppressive Status of H
Xie Y; Zhang Y; Wei X; Zhou C; Huang Y; Zhu X; Chen Y; Wen H; Huang X; Lin J; Wang Z; Ren Y; Fan B; Deng X; Tan W; Wang C
Front Pharmacol; 2020; 11():16. PubMed ID: 32140106
[TBL] [Abstract][Full Text] [Related]
12. Regulation of ROS in myeloid-derived suppressor cells through targeting fatty acid transport protein 2 enhanced anti-PD-L1 tumor immunotherapy.
Adeshakin AO; Liu W; Adeshakin FO; Afolabi LO; Zhang M; Zhang G; Wang L; Li Z; Lin L; Cao Q; Yan D; Wan X
Cell Immunol; 2021 Apr; 362():104286. PubMed ID: 33524739
[TBL] [Abstract][Full Text] [Related]
13. Exosomal Hsp70 mediates immunosuppressive activity of the myeloid-derived suppressor cells via phosphorylation of Stat3.
Diao J; Yang X; Song X; Chen S; He Y; Wang Q; Chen G; Luo C; Wu X; Zhang Y
Med Oncol; 2015 Feb; 32(2):453. PubMed ID: 25603952
[TBL] [Abstract][Full Text] [Related]
14. A cohort study using IL-6/Stat3 activity and PD-1/PD-L1 expression to predict five-year survival for patients after gastric cancer resection.
Li XN; Peng YH; Yue W; Tao L; Zhang WJ
PLoS One; 2022; 17(12):e0277908. PubMed ID: 36454780
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of myeloid-derived suppressive cell function with all-trans retinoic acid enhanced anti-PD-L1 efficacy in cervical cancer.
Liang Y; Wang W; Zhu X; Yu M; Zhou C
Sci Rep; 2022 Jun; 12(1):9619. PubMed ID: 35688951
[TBL] [Abstract][Full Text] [Related]
16. Helicobacter pylori CagA promotes immune evasion of gastric cancer by upregulating PD-L1 level in exosomes.
Wang J; Deng R; Chen S; Deng S; Hu Q; Xu B; Li J; He Z; Peng M; Lei S; Ma T; Chen Z; Zhu H; Zuo C
iScience; 2023 Dec; 26(12):108414. PubMed ID: 38047083
[TBL] [Abstract][Full Text] [Related]
17. Tumor-associated GM-CSF overexpression induces immunoinhibitory molecules via STAT3 in myeloid-suppressor cells infiltrating liver metastases.
Thorn M; Guha P; Cunetta M; Espat NJ; Miller G; Junghans RP; Katz SC
Cancer Gene Ther; 2016 Jun; 23(6):188-98. PubMed ID: 27199222
[TBL] [Abstract][Full Text] [Related]
18. IFNAR1 Controls Autocrine Type I IFN Regulation of PD-L1 Expression in Myeloid-Derived Suppressor Cells.
Xiao W; Klement JD; Lu C; Ibrahim ML; Liu K
J Immunol; 2018 Jul; 201(1):264-277. PubMed ID: 29752314
[TBL] [Abstract][Full Text] [Related]
19. Reactive oxygen species reprogram macrophages to suppress antitumor immune response through the exosomal miR-155-5p/PD-L1 pathway.
Li X; Wang S; Mu W; Barry J; Han A; Carpenter RL; Jiang BH; Peiper SC; Mahoney MG; Aplin AE; Ren H; He J
J Exp Clin Cancer Res; 2022 Jan; 41(1):41. PubMed ID: 35086548
[TBL] [Abstract][Full Text] [Related]
20. Gastric cancer-derived exosomes facilitate pulmonary metastasis by activating ERK-mediated immunosuppressive macrophage polarization.
Gu J; Chu X; Huo Y; Liu C; Chen Q; Hu S; Pei Y; Ding P; Pang S; Wang M
J Cell Biochem; 2023 Apr; 124(4):557-572. PubMed ID: 36842167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
